Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07RPV
|
||||
| Former ID |
DNC008843
|
||||
| Drug Name |
HALOPEMIDE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529914] | ||
| Formula |
C21H22ClFN4O2
|
||||
| Canonical SMILES |
C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCNC(=O)C4=CC=C(C=C4)<br />F
|
||||
| InChI |
1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)
|
||||
| InChIKey |
NBHPRWLFLUBAIE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Phospholipase D1 | Target Info | Inhibitor | [529914] | |
| Phospholipase D | Target Info | Inhibitor | [529914] | ||
| BioCyc Pathway | Phospholipases | ||||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Ether lipid metabolism | |||||
| Metabolic pathways | |||||
| Ras signaling pathway | |||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Endocytosis | |||||
| Fc gamma R-mediated phagocytosis | |||||
| Glutamatergic synapse | |||||
| GnRH signaling pathway | |||||
| Pathways in cancer | |||||
| Pancreatic cancer | |||||
| Choline metabolism in cancer | |||||
| PANTHER Pathway | Angiogenesis | ||||
| Ras Pathway | |||||
| WikiPathways | EGF/EGFR Signaling Pathway | ||||
| TSH signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.